United Therapeutics (UTHR) director Ray Kurzweil vests 650 RSUs into stock
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
UNITED THERAPEUTICS Corp director Ray Kurzweil reported the vesting and exercise of 650 restricted stock units into an equal number of shares of common stock on July 9, 2026. The RSUs converted on a one-for-one basis with no exercise price. Following the transaction, Kurzweil holds 13,320 shares of common stock directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
650 shares exercised/converted
Mixed
2 txns
Insider
KURZWEIL RAY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 650 | $0.00 | -- |
| Exercise | Common Stock | 650 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 13,320 shares (Direct)
Footnotes (1)
- Shares received upon vesting of restricted stock units on July 9, 2026. Restricted stock units converted on a one-for-one basis into shares of common stock. Not applicable as restricted stock units do not have an expiration date.
Key Figures
RSUs converted: 650 shares
Exercise price: $0.0000 per share
Shares held after transaction: 13,320 shares
3 metrics
RSUs converted
650 shares
Restricted stock units converted one-for-one into common stock on July 9, 2026
Exercise price
$0.0000 per share
Conversion price for restricted stock units into common stock
Shares held after transaction
13,320 shares
Ray Kurzweil’s direct common stock holdings following the RSU conversion
Key Terms
Restricted Stock Units, derivative security, vesting
3 terms
Restricted Stock Units financial
"Shares received upon vesting of restricted stock units on July 9, 2026"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"Shares received upon vesting of restricted stock units on July 9, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What did Ray Kurzweil report in this Form 4 for UTHR?
Ray Kurzweil reported the vesting and conversion of 650 restricted stock units into 650 shares of UNITED THERAPEUTICS Corp common stock on July 9, 2026, with no exercise price.
Was there a cash exercise price for the UTHR restricted stock units?
No cash exercise price applied. The restricted stock units converted at $0.0000 per share, meaning the RSUs vested and automatically became common shares without a purchase payment.
What type of derivative security did Ray Kurzweil convert at UTHR?
Ray Kurzweil converted restricted stock units, classified as a derivative security, into 650 shares of UNITED THERAPEUTICS Corp common stock on a one-for-one basis upon vesting.
Do the UTHR restricted stock units reported have an expiration date?
The filing notes that an expiration date is not applicable because the restricted stock units do not have an expiration date; they converted into common stock upon vesting.